KATIE STEMMERICH: Open Payments
NPI 1538500319 · GROVE CITY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 17 payments from 4 companies in 2025. Trend: 2023 $575 · 2024 $1,033 · 2025 $439
Food & beverage: $374Education: $65
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $197 |
| Novo Nordisk Inc | 10 | $197 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: MOUNJARO, Ozempic, Rybelsus, Kerendia, JARDIANCE.
Industry payments across PA — which companies pay providers there.
